127 related articles for article (PubMed ID: 7448791)
1. Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans.
Rosenblum MG; Stewart DJ; Yap BS; Leavens M; Benjamin RS; Loo TL
Cancer Res; 1981 Feb; 41(2):459-62. PubMed ID: 7448791
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of [14C]methylglyoxal-bis-guanylhydrazone) in patients with leukemia.
Rosenblum MG; Keating MJ; Yap BS; Loo TL
Cancer Res; 1981 May; 41(5):1748-50. PubMed ID: 7214342
[TBL] [Abstract][Full Text] [Related]
3. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL
Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649
[TBL] [Abstract][Full Text] [Related]
4. Disposition of methylglyoxal bis(guanylhydrazone) (MGBG, NSC-32946) in man.
Stewart DJ; Rosenblum MG; Luna M; Loo TL
Cancer Chemother Pharmacol; 1981; 7(1):31-5. PubMed ID: 6280886
[TBL] [Abstract][Full Text] [Related]
5. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice.
Kramer DL; Paul B; Porter CW
Cancer Res; 1985 Jun; 45(6):2512-5. PubMed ID: 3921245
[TBL] [Abstract][Full Text] [Related]
6. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
[TBL] [Abstract][Full Text] [Related]
7. Combined use of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in normal and leukemia-bearing mice.
Seppänen P; Alhonen-Hongisto L; Jänne J
Cancer Lett; 1983 Feb; 18(1):1-10. PubMed ID: 6402294
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary accumulation of methylglyoxal-bis(guanylhydrazone) by the oligoamine uptake system.
Gordonsmith RH; Smith LL; Cohen GM
Biochem Pharmacol; 1985 May; 34(10):1809-16. PubMed ID: 4004896
[TBL] [Abstract][Full Text] [Related]
9. Analysis of methylglyoxal bis(guanylhydrazone)-induced alterations of hamster tumor mitochondria by correlated studies of selective rhodamine binding, ultrastructural damage, DNA replication, and reversibility.
Nass MM
Cancer Res; 1984 Jun; 44(6):2677-88. PubMed ID: 6722801
[TBL] [Abstract][Full Text] [Related]
10. Comparison of specificity of inhibition of polyamine synthesis in bovine lymphocytes by ethylglyoxal bis(guanylhydrazone) and methylglyoxal bis(guanylhydrazone).
Igarashi K; Porter CW; Morris DR
Cancer Res; 1984 Nov; 44(11):5326-31. PubMed ID: 6488187
[TBL] [Abstract][Full Text] [Related]
11. Isolation and uptake characteristics of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
Wiseman A; Kramer DL; Porter CW
Cancer Res; 1983 Dec; 43(12 Pt 1):5937-42. PubMed ID: 6315222
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitization by methylglyoxal bis(guanylhydrazone) in Chinese hamster cells.
Miyakoshi J; Heki S
Radiat Res; 1983 Dec; 96(3):523-31. PubMed ID: 6657920
[TBL] [Abstract][Full Text] [Related]
13. Carrier-mediated uptake of methylglyoxal bis(guanylhydrazone) by rat lungs perfused in situ.
Rannels DE; Addison JL; Pegg AE
Am J Physiol; 1985 Mar; 248(3 Pt 1):E292-8. PubMed ID: 3976883
[TBL] [Abstract][Full Text] [Related]
14. Remarkable differences between the species distributions of various bis(guanylhydrazones) at physiological conditions, and their possible involvement in the strict structural requirements for antileukemic activity.
Elo HO; Tilus PT; Mutikainen IP; Heikkinen I; Riekkola ML
Anticancer Drug Des; 1989 Dec; 4(4):303-9. PubMed ID: 2619868
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and chemical characterization of phenylglyoxal bis(guanylhydrazone), an aromatic analogue of mitoguazone.
Elo H; Koskinen M; Mutikainen I; Tilus P; Lampio A; Keso L; Vainio A; Joutsjoki V; Alli K; Yliniva A
Anticancer Drug Des; 1996 Oct; 11(7):493-508. PubMed ID: 8921933
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic analysis of the anticancer agent methylglyoxal bis(guanylhydrazone) (MGBG, NSC-32946) in biological fluids.
Rosenblum MG; Loo TL
J Chromatogr; 1980 Sep; 183(3):363-6. PubMed ID: 7419655
[No Abstract] [Full Text] [Related]
17. Percutaneous penetration of methylglyoxal bis(guanylhydrazone): effects on hairless mouse epidermis in vivo.
McCullough JL; Weinstein GD; Rosenblum MG; Jenkins JJ
J Invest Dermatol; 1983 Nov; 81(5):388-92. PubMed ID: 6415178
[TBL] [Abstract][Full Text] [Related]
18. Differential toxicity of methylglyoxal-bis [guanylhydrazone].
Dewey DL; Gaugas JM; Stratford MR; Minchinton AI
J Pathol; 1983 Feb; 139(2):141-9. PubMed ID: 6827399
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of thermal cell killing by methylglyoxal bis(guanylhydrazone) in Chinese hamster V-79 cells.
Miyakoshi J; Heki S
Gan; 1983 Apr; 74(2):226-31. PubMed ID: 6862143
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the antimitochondrial and antiproliferative effects of bis(guanylhydrazones) by phenethylbiguanide.
Byczkowski JZ; Zychlinski L; Porter CW
Cancer Res; 1982 Sep; 42(9):3592-5. PubMed ID: 6896674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
